Molecular analysis of the TSC1 gene in adenocarcinoma of the lung

Lung Cancer

Volumn 46, Issue 3, 2004, Pages 271-281

  Takamochi, Kazuya ^a,b   Ogura, Tsutomu ^a   Yokose, Tomoyuki ^a   Ochiai, Atsushi ^a   Nagai, Kanji ^a   Nishiwaki, Yutaka ^a   Suzuki, Kazuya ^b   Esumi, Hiroyasu ^a  

^a NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^b HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Adenocarcinoma; Atypical adenomatous hyperplasia; Loss of heterozygosity; Lung cancer; Mutation; TSC1 gene

Indexed keywords

DNA;

ADULT; AGED; ARTICLE; CANCER SCREENING; CANCER TISSUE; CARCINOGENESIS; CLINICAL ARTICLE; CONTROLLED STUDY; DNA EXTRACTION; EXON; FEMALE; FREEZING; GENE; GENE MUTATION; GENETIC ANALYSIS; HETEROZYGOSITY LOSS; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG ADENOCARCINOMA; MALE; MICRODISSECTION; MOLECULAR BIOLOGY; PATHOGENESIS; PRIORITY JOURNAL; SAMPLE; TSC1 GENE; TUMOR; TUMOR CELL; TUMOR SUPPRESSOR GENE;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; DNA METHYLATION; DNA MUTATIONAL ANALYSIS; DNA, NEOPLASM; FEMALE; GENES, TUMOR SUPPRESSOR; HUMANS; LOSS OF HETEROZYGOSITY; LUNG NEOPLASMS; MALE; MIDDLE AGED; PROTEINS; TUMOR SUPPRESSOR PROTEINS;

EID: 8444220440     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2004.05.001     Document Type: Article

References (31)

1. Identification and characterization of the tuberous sclerosis gene on chromosome 16, The European Chromosome 16 Tuberous Sclerosis Consortium, Cell 1993; 75: 1305-15.
2. van Slegtenhorst M., de Hoogt R., Hermans C., Nellist M., Janssen B., Verhoef S., et al. Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34. Science. 277:1997;805-808
3. Capron F., Ameille J., Leclerc P., Mornet P., Barbagellata M., Reynes M., et al. Pulmonary lymphangioleiomyomatosis and Bourneville's tuberous sclerosis with pulmonary involvement: the same disease? Cancer. 52:1983;851-855
4. Muir T.E., Leslie K.O., Popper H., Kitaichi M., Gagne E., Emelin J.K., et al. Micronodular pneumocyte hyperplasia. Am. J. Surg. Pathol. 22:1998;465-472
5. Guinee D., Singh R., Azumi N., Singh G., Przygodzki R.M., Travis W., et al. Multifocal micronodular pneumocyte hyperplasia: a distinctive pulmonary manifestation of tuberous sclerosis. Mod. Pathol. 8:1995;902-906
6. World Health Organization, Histological Typing of Lung and Pleural Tumours. 3rd ed. Berlin, Heidelberg, Springer-Verlag, 1999.
7. Suzuki K., Ogura T., Yokose T., Nagai K., Mukai K., Kodama T., et al. Loss of heterozygosity in the tuberous sclerosis gene associated regions in adenocarcinoma of the lung accompanied by multiple atypical adenomatous hyperplasia. Int. J. Cancer. 79:1998;384-389
8. Takamochi K., Ogura T., Suzuki K., Kawasaki H., Kurashima Y., Yokose T., et al. Loss of heterozygosity on chromosomes 9q and 16p in atypical adenomatous hyperplasia concomitant with adenocarcinoma of the lung. Am. J. Pathol. 159:2001;1941-1948
9. Green A.J., Smith M., Yates J.R. Loss of heterozygosity on chromosome 16p13.3 in hamartomas from tuberous sclerosis patients. Nat. Genet. 6:1994;193-196
10. Green A.J., Johnson P.H., Yates J.R. The tuberous sclerosis gene on chromosome 9q34 acts as a growth suppressor. Hum. Mol. Genet. 3:1994;1833-1834
11. Sepp T., Yates J.R., Green A.J. Loss of heterozygosity in tuberous sclerosis hamartomas. J. Med. Genet. 33:1996;962-964
12. Gomez MR, Sampson JR. V H-W. Tuberous sclerosis complex. 3rd ed. New York: Oxford University Press, 1999.
13. Guang S.G., Ogura T., Sekine I., Yokozaki M., Esumi H., Kodama T., et al. Association between p53 mutation and clinicopathological features of non-small cell lung cancer. Jpn. J. Clin. Oncol. 27:1997;211-215
14. Shiseki M., Kohno T., Nishikawa R., Sameshima Y., Mizoguchi H., Yokota J., et al. Frequent allelic losses on chromosomes 2q, 18q, and 22q in advanced non-small-cell lung carcinoma. Cancer Res. 54:1994;5643-5648
15. Yatabe Y., Konishi H., Mitsudomi T., Nakamura S., Takahashi T. Topographical distributions of allelic loss in individual non-small-cell lung cancers. Am. J. Pathol. 157:2000;985-993
16. Yamasaki M., Takeshima Y., Fujii S., Matsuura M., Tagawa K., Inai K., et al. Correlation between morphological heterogeneity and genetic alteration within one tumor in adenocarcinomas of the lung. Pathol. Int. 50:2000;891-896
17. Hung J., Kishimoto Y., Sugio K., Virmani A., McIntire D.D., Minna J.D., et al. Allele-specific chromosome 3p deletions occur at an early stage in the pathogenesis of lung carcinoma [published erratum appears in JAMA 1995 Jun 28273(24):1908]. JAMA. 273:1995;558-563
18. Kishimoto Y., Sugio K., Hung J.Y., Virmani A.K., McIntire D.D., Minna J.D., et al. Allele-specific loss in chromosome 9p loci in preneoplastic lesions accompanying non-small-cell lung cancers. J. Natl. Cancer Inst. 87:1995;1224-1229
19. Kitaguchi S., Takeshima Y., Nishisaka T., Inai K. Proliferative activity, p53 expression and loss of heterozygosity on 3p, 9p and 17p in atypical adenomatous hyperplasia of the lung. Hiroshima J. Med. Sci. 47:1998;17-25
20. Kohno H., Hiroshima K., Toyozaki T., Fujisawa T., Ohwada H. p53 Mutation and allelic loss of chromosome 3p, 9p of preneoplastic lesions in patients with nonsmall cell lung carcinoma. Cancer. 85:1999;341-347
21. Cooper C.A., Carby F.A., Bubb V.J., Lamb D., Kerr K.M., Wyllie A.H., et al. The pattern of K-ras mutation in pulmonary adenocarcinoma defines a new pathway of tumour development in the human lung. J. Pathol. 181:1997;401-404
22. Westra W.H., Baas I.O., Hruban R.H., Askin F.B., Wilson K., Offerhaus G.J., et al. K-ras oncogene activation in atypical alveolar hyperplasias of the human lung. Cancer Res. 56:1996;2224-2228
23. Knudson A.G. Jr. Mutation and cancer: statistical study of retinoblastoma. Proc. Natl. Acad. Sci. U.S.A. 68:1971;820-823
24. Tsou J.A., Hagen J.A., Carpenter C.L., Laird-Offringa I.A. DNA methylation analysis: a powerful new tool for lung cancer diagnosis. Oncogene. 21:2002;5450-5461
25. Zochbauer-Muller S., Fong K.M., Virmani A.K., Geradts J., Gazdar A.F., Minna J.D., et al. Aberrant promoter methylation of multiple genes in non-small cell lung cancers. Cancer Res. 61:2001;249-255
26. Issa J.P., Ottaviano Y.L., Celano P., Hamilton S.R., Davidson N.E., Baylin S.B., et al. Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colon. Nat. Genet. 7:1994;536-540
27. Ahuja N., Li Q., Mohan A.L., Baylin S.B., Issa J.P. Aging and DNA methylation in colorectal mucosa and cancer. Cancer Res. 58:1998;5489-5494
28. Shepherd C.W., Gomez M.R., Lie J.T., Crowson C.S. Causes of death in patients with tuberous sclerosis. Mayo Clin. Proc. 66:1991;792-796
29. Tang B., Bottinger E.P., Jakowlew S.B., Bagnall K.M., Mariano J., Anver M.R., et al. Transforming growth factor-beta1 is a new form of tumor suppressor with true haploid insufficiency. Nat. Med. 4:1998;802-807
30. Shibata M.A., Liu M.L., Knudson M.C., Shibata E., Yoshidome K., Bandey T., et al. Haploid loss of bax leads to accelerated mammary tumor development in C3(1)/SV40-TAg transgenic mice: reduction in protective apoptotic response at the preneoplastic stage. EMBO J. 18:1999;2692-2701
31. Niida Y., Stemmer-Rachamimov A.O., Logrip M., Tapon D., Perez R., Kwiatkowski D.J., et al. Survey of somatic mutations in tuberous sclerosis complex (TSC) hamartomas suggests different genetic mechanisms for pathogenesis of TSC lesions. Am. J. Hum. Genet. 69:2001;493-503